Opko Health, Inc.
Clinical trials sponsored by Opko Health, Inc., explained in plain language.
-
New hope for kids with kidney disease: vitamin d capsule trial launches
Disease control Not yet recruitingThis study tests an extended-release vitamin D capsule (CTAP101) in 40 children aged 8 to 17 with stage 3 or 4 chronic kidney disease, secondary hyperparathyroidism, and low vitamin D. Participants take one capsule daily at bedtime for 8 weeks. The goal is to see how the body pro…
Phase: PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated May 26, 2026 11:05 UTC
-
New MASH drug enters early human testing – could it ease fatty liver?
Disease control Not yet recruitingThis early-stage study tests a new drug called OPK-88006 in healthy volunteers and people with MASH, a serious fatty liver condition. The main goals are to check safety, how the drug moves through the body, and early signs it might help the liver. About 30 participants will take …
Phase: PHASE1, PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated May 18, 2026 12:04 UTC